Deutsche Bank
AGL icon

Deutsche Bank’s Agilon Health AGL Stock Holding History

Deutsche Bank’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.2K Sell
10,009
-18,040
-64% -$292K ﹤0.01% 3351
2025
Q4 		$484K Sell
28,049
-1,306
-4% -$25.3K ﹤0.01% 2587
2025
Q3 		$756K Sell
29,355
-8,660
-23% -$327K ﹤0.01% 2329
2025
Q2 		$2.19M Sell
38,015
-9,416
-20% -$755K ﹤0.01% 1650
2025
Q1 		$5.13M Sell
47,431
-770
-2% -$67K ﹤0.01% 1244
2024
Q4 		$2.29M Sell
48,201
-35,296
-42% -$2.13M ﹤0.01% 1764
2024
Q3 		$8.2M Buy
83,497
+9,561
+13% +$1.23M ﹤0.01% 1081
2024
Q2 		$12.1M Buy
73,936
+21,856
+42% +$3.11M 0.01% 947
2024
Q1 		$7.94M Sell
52,080
-2,413
-4% -$401K ﹤0.01% 1105
2023
Q4 		$17.1M Buy
54,493
+726
+1% +$263K 0.01% 834
2023
Q3 		$23.9M Sell
53,767
-826
-2% -$373K 0.02% 661
2023
Q2 		$23.7M Buy
54,593
+6,667
+14% +$3.75M 0.01% 722
2023
Q1 		$28.5M Buy
47,926
+7,906
+20% +$4.43M 0.02% 666
2022
Q4 		$16.1M Sell
40,020
-10,949
-21% -$5.13M 0.01% 818
2022
Q3 		$29.8M Buy
50,969
+10,974
+27% +$6.57M 0.02% 651
2022
Q2 		$21.8M Sell
39,995
-4,566
-10% -$2.31M 0.01% 764
2022
Q1 		$28.2M Sell
44,561
-3,872
-8% -$2M 0.01% 748
2021
Q4 		$32.7M Buy
48,433
+5,753
+13% +$3.5M 0.01% 714
2021
Q3 		$28M Buy
42,680
+36,840
+631% +$31.5M 0.01% 780
2021
Q2 		$5.92M Buy
+5,840
New +$5.12M ﹤0.01% 1423

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank's AGL Position: Q1 2026 in Review

Deutsche Bank reduced its Agilon Health (AGL) stake by 64% in Q1 2026, selling an estimated $292K and leaving 10,009 shares worth $79.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

Deutsche Bank first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $32.7M in Q4 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Deutsche Bank held 10,009 shares of Agilon Health worth $79.2K as of Q1 2026.
  • Deutsche Bank sold 18,040 Agilon Health shares in Q1 2026, an estimated $292K.
  • Agilon Health made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3351 holding.
  • Deutsche Bank first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
  • Deutsche Bank's Agilon Health position peaked at $32.7M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.